1. Home
  2. NURO vs DSS Comparison

NURO vs DSS Comparison

Compare NURO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • DSS
  • Stock Information
  • Founded
  • NURO 1996
  • DSS 1984
  • Country
  • NURO United States
  • DSS United States
  • Employees
  • NURO N/A
  • DSS N/A
  • Industry
  • NURO Medical/Dental Instruments
  • DSS Containers/Packaging
  • Sector
  • NURO Health Care
  • DSS Consumer Discretionary
  • Exchange
  • NURO Nasdaq
  • DSS Nasdaq
  • Market Cap
  • NURO 8.2M
  • DSS 7.3M
  • IPO Year
  • NURO N/A
  • DSS N/A
  • Fundamental
  • Price
  • NURO $4.38
  • DSS $0.95
  • Analyst Decision
  • NURO
  • DSS
  • Analyst Count
  • NURO 0
  • DSS 0
  • Target Price
  • NURO N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • NURO 19.9K
  • DSS 18.3K
  • Earning Date
  • NURO 02-24-2025
  • DSS 03-26-2025
  • Dividend Yield
  • NURO N/A
  • DSS N/A
  • EPS Growth
  • NURO N/A
  • DSS N/A
  • EPS
  • NURO N/A
  • DSS N/A
  • Revenue
  • NURO $3,767,764.00
  • DSS $25,019,000.00
  • Revenue This Year
  • NURO N/A
  • DSS N/A
  • Revenue Next Year
  • NURO N/A
  • DSS N/A
  • P/E Ratio
  • NURO N/A
  • DSS N/A
  • Revenue Growth
  • NURO N/A
  • DSS N/A
  • 52 Week Low
  • NURO $2.66
  • DSS $0.77
  • 52 Week High
  • NURO $4.73
  • DSS $2.30
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.35
  • DSS 56.49
  • Support Level
  • NURO $4.16
  • DSS $0.81
  • Resistance Level
  • NURO $4.39
  • DSS $0.97
  • Average True Range (ATR)
  • NURO 0.06
  • DSS 0.07
  • MACD
  • NURO 0.00
  • DSS 0.01
  • Stochastic Oscillator
  • NURO 91.56
  • DSS 81.82

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: